Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
Byhardt
R W
RW
Medical College of Wisconsin, Milwaukee, USA.
Sause
W T
WT
Curran
W J
WJ
Fuller
D
D
Graham
M V
MV
Ko
B
B
Komaki
R
R
Weisenburger
T H
TH
Kaiser
L R
LR
Leibel
S A
SA
Choi
N C
NC
D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011013:Pneumonectomy; D015996:Survival Rate